Advertisement

Topics

Latest "Biosciences" News Stories

19:20 EDT 15th July 2018 | BioPortfolio

Here are the most relevant search results for "Biosciences" found in our extensive news archives from over 250 global news sources.

More Information about Biosciences on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Biosciences for you to read. Along with our medical data and news we also list Biosciences Clinical Trials, which are updated daily. BioPortfolio also has a large database of Biosciences Companies for you to search.

Showing "Biosciences" News Articles 1–25 of 1,100+

Relevant

ASC Biosciences, Inc. announces ad dates for first television commercial

About ASC Biosciences, Inc.ASC Biosciences, Inc. ("ASC" or the "Company") is a development stage biotechnology company with a proprietary adult stem cell platform capable Read more...


SOLID BIOSCIENCES INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing in Solid Biosciences Inc. to Contact The Firm

NEW YORK, NY / ACCESSWIRE / April 9, 2018 / Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Solid Biosciences Inc. ("Solid Biosciences" or th...

African Women for Biosciences Platform Launched

Women in biosciences remain grossly under represented in leadership and decision-making levels, limiting contribution of scientific research to national development. A new platform - the African Women for Biosciences (AWfB), launched on May 10, 2018 in Nairobi aims to address some of the challenges faced by women in biosciences. The event was part ...


Apricus Biosciences, Inc.: Apricus Biosciences Announces Proposed Public Offering

SAN DIEGO, March 27, 2018 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that ...

Apricus Biosciences, Inc.: Apricus Biosciences Receives Complete Response Letter from FDA for Vitaros

Company Evaluating Deficiencies and Potential Path Forward SAN DIEGO, Feb. 16, 2018 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative me...

Kaskela Law LLC: IMPORTANT SHAREHOLDER DEADLINE ALERT: Solid Biosciences, Inc. - SLDB

RADNOR, PA / ACCESSWIRE / May 23, 2018 / Kaskela Law LLC reminds Solid Biosciences, Inc. (NASDAQ: SLDB) ("Solid Biosciences" or the "Company") investors that a class action complaint has been filed...

SOLID BIOSCIENCES SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF ...

Solid Biosciences investors should visit us at https://www.claimsfiler.com/cases/view-solid-biosciences-inc-securities-litigationor call to speak to our claim center toll-free at (844) 367-9658.   About the Lawsuit Solid Read more...

AB Biosciences & Shire Enter License Agreement

For AB Biosciences' pan receptor interacting molecule (PRIM) program

Shire plc: AB Biosciences and Shire Enter Into Agreement for Development and Commercialization of AB Biosciences' PRIM Program

AB Biosciences and Shire Enter Into Agreement for Development and Commercialization of AB Biosciences' PRIM Program for Potential Treatment of Autoimmune Diseases and Other Immune-Mediated Disorde...

Shire to develop AB Biosciences’ platform for autoimmune diseases

Shire has obtained exclusive worldwide licence for the development and commercialisation of US-based AB Biosciences’ pan receptor interacting molecule (PRIM)...Read More... The post Shire to develop AB Biosciences’ platform for autoimmune diseases appeared first on Pharmaceutical Technology.

Pawar Law Group: Solid Biosciences Inc. Reminder: Important May 29, 2018 Lead Plaintiff Deadline in Class Action - SLDB

NEW YORK, NY / ACCESSWIRE / April 20, 2018 / Pawar Law Group reminds shareholders who purchased shares of Solid Biosciences Inc. (NASDAQ: SLDB): (1) in Solid Biosciences' initial public offering on...

#news #biotech Arcus Biosciences eyes $100M IPO

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Arcus Biosciences eyes $100M IPO .Mere months after bagging $107 million in its series C round, Arcus Biosciences is teeing up for a $100 million IPO, which will … Continue reading → Cet article #news #biotech Arcus Biosciences eyes $100M IPO est apparu en premier ...

Solid Biosciences hit hard by study stoppage

Duchenne’s muscular dystrophy (DMD) specialist Solid Biosciences has been told by the US Food and…

Sygnis acquires TGR BioSciences for €10.1mm

Sygnis AG brought in a complementary genomics/proteomics portfolio through the €10.1mm ($12mm) (net of cash) acquisition of...

Eli Lilly closes $1.6bn ARMO BioSciences acquisition

Eli Lilly has completed the acquisition of immuno-oncology company ARMO BioSciences in an all-cash deal valued at nearly $1.6bn. Lilly...Read More... The post Eli Lilly closes $1.6bn ARMO BioSciences acquisition appeared first on Pharmaceutical Technology.

Brii Biosciences options up to four Vir programs in China

Brii Biosciences launched and entered into an option agreement with Vir Biotechnology Inc.

SHAREHOLDER ALERT: Kessler Topaz Meltzer & Check, LLP Announces Class Action Lawsuit Filed Against Solid Biosciences, Inc. -- SLDB

RADNOR, PA / ACCESSWIRE / March 30, 2018 / The law firm of Kessler Topaz Meltzer & Check, LLP alerts Solid Biosciences, Inc. (NASDAQ: SLDB) ("Solid Biosciences" or the "Company") shareholders that ...

Vortex Biosciences announces management changes

Bob Englert has been promoted from chief technology officer to CEO at Vortex Biosciences, replacing Gene Walther who has resi -More- 

Arcus Biosciences files for IPO

Arcus Biosciences Inc. (cancer immunotherapies) filed for its initial public offering.

In The Spotlight: Catalyst Biosciences

Shares of Catalyst Biosciences Inc. (CBIO) are up an impressive 100% year-to-date in sharp contrast to the NASDAQ Biotechnology Index, which is down nearly 2% during the same period.

Evelo Biosciences files for IPO

Evelo Biosciences Inc. (therapeutics for inflammatory diseases and cancer based on the gut-body network) filed for an initial...

Aptose Biosciences (APTO) vs. Arena Pharmaceuticals (ARNA) Head to Head Contrast

Aptose Biosciences and Arena Pharmaceuticals are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, dividends, risk, profitability, institutional ownership, valuation and analyst recommendations. This is a breakdown of recent ratings and target prices for Aptose Biosciences and Arena Pharmaceuticals, as pr...

BRIEF—Dyve Biosciences launches as dermal delivery technology company

Dyve Biosciences officially launched today as a new face in the biopharmaceutical space in Thousand Oaks,…

Pawar Law Group: Solid Biosciences Inc. Reminder: Pawar Law Reminds of Important May 29, 2018 Lead Plaintiff Deadline in Class Action- SLDB

NEW YORK, NY / ACCESSWIRE / May 25, 2018 / Pawar Law Group reminds shareholders who purchased shares of Solid Biosciences Inc. (NASDAQ: SLDB): (1) in Solid Biosciences' initial public offering on o...

Batavia Biosciences joins project to develop new polio vaccine

Biopharmaceutical manufacturer Batavia Biosciences is joining an international consortium to sustain a polio-free world once the disease has been eradicated....Read More... The post Batavia Biosciences joins project to develop new polio vaccine appeared first on Pharmaceutical Technology.


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks